fulvestrant has been researched along with benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aronovitz, MJ; Baur, J; Celestin, F; Chen, X; Force, T; Grohe, C; Haq, S; Karas, RH; Mendelsohn, ME; Michael, A; Nuedling, S; Patten, RD; Pourati, I | 1 |
1 other study(ies) available for fulvestrant and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
| Article | Year |
|---|---|
17beta-estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling.
Topics: Amino Acid Chloromethyl Ketones; Androstadienes; Animals; Apoptosis; Cells, Cultured; Chromones; Enzyme Activation; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Morpholines; Myocardial Infarction; Myocytes, Cardiac; Ovariectomy; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Recombinant Fusion Proteins; Signal Transduction; Wortmannin | 2004 |